Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials

Table 3 Baseline characteristics of patients from the included studies

Study/Year	Age (yrs)	Male (%)	Ht (%)	Hc (%)	Cs (%)	Q^a
Study/Year	T/D	T/D	T/D	T/D	T/D
Lee 2007 [34]	60.9/61.2	64.8/63.6	54.8/55.2	30.0/28.4	37.6/37.2	B
Lee 2008 [5]	61.0/60.7	59.0/57.0	59.5/59.5	30.5/28.5	24.0/31.5	B
Yang 2011 [35]	63.5/63.5	62.3/62.3	55.8/55.8	37.7/37.7	28.6/28.6	B
Yang 2009 [36]	63.4/63.8	40.0/60.0	61.9/57.1	28.6/41.2	14.3/20.6	B
Capranzano 2012 [37]	60.4/60.4	60.2/60.2	91.2/91.2	97.0/97.0	37.1/37.1	B
Angiolillo 2008 [38]	64.0/64.0	60.0/60.0	96.0/96.0	92.0/92.0	24.0/24.0	B
Angiolillo 2011 [39]	60.5/60.5	63.0/63.0	95.0/95.0	100.0/100.0	28.0/28.0	B
Ha 2013 [40]	64.9/62.3	67.7/76.1	71.4/76.1	33.3/42.5	23.8/23.8	B
Lee 2011 [33]	60.9/62.1	70.0/71.5	58.4/64.7	42.4/45.0	30.4/30.1	B
Han 2009 [6]	59.6/60.2	73.8/72.9	57.9/56.1	45.5/45.4	–	B

Abbreviations:NM not mentioned, Ht hypertension, Hc hypercholesterolemia; Cs current smoker, T triple therapy, D dual therapy
^aQuality scale: A:true randomization and allocation concealed; B:process of randomization not given and concealment of allocation unclear

ISSN: 1471-2261